Emergent Risk Group-4 (RG-4) Filoviruses: A paradox in progress

Bioinformation. 2023 Aug 31;19(8):829-832. doi: 10.6026/97320630019829. eCollection 2023.ABSTRACTFiloviruses, categorized as World Health Organization (WHO) Risk Group 4 (RG-4) pathogens, represent significant global health risks due to their extraordinary virulence. The Filoviridae family encompasses Ebola strains such as Sudan, Zaire, Bundibugyo, Tai Forest (formerly known as Ivory Coast), Reston, and Bombali, in addition to the closely related Marburg and Ravn virus strains. Filoviruses originated from a common ancestor about 10,000 years ago and displayed remarkable consistency in genetic heterogeneity until the 20th century. However, they overcame a genetic bottleneck by mid-century. Paradoxically, this resulted in the emergence of boosted virulent strains from the 1970's onward. Filovirus research is included in the NIAID Biodefense Program and utilizes the highest level specialized protective laboratories, Biosafety Laboratory (BSL)-4. The spread of Filoviruses as well as other RG-4 pathogens within Africa poses a significant health threat increasingly both in Africa and out of Africa.PMID:37908613 | PMC:PMC10613816 | DOI:10.6026/97320630019829
Source: Bioinformation - Category: Bioinformatics Authors: Source Type: research